Tvardi Therapeutics, Inc. (TVRD) SEC filings

TVRD SEC filings moved a median of -0.89% by the close. TVRD SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TVRD overview →

34 measured TVRD SEC filing events.

Where these TVRD SEC filings landedvs 34 measured TVRD SEC filing reactions
TVRD SEC filingMiddle 50% · -3.86% to +2.31%Zero: 0.00%Median: -0.89%Median -0.89%-5.00%0+5.00%
Middle 50% of TVRD SEC filing reactions-3.86% to +2.31%
Median reaction (to close)-0.89%
Measured reactions34
Point-in-time · zero look-ahead

Half of the 34 TVRD SEC filing events with a measured close landed between -3.86% and +2.31%; 44% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Tvardi Therapeutics, For: Jun 30SEC filing · Form 10-Q+4.97%+4.97%
Form 8-K Tvardi Therapeutics, For: Aug 14SEC filing · Form 8-K+4.97%+4.97%
Form 8-K Tvardi Therapeutics, For: Jul 30SEC filing · Form 8-K+0.00%-0.94%
Form 8-K Tvardi Therapeutics, For: Jul 17SEC filing · Form 8-K-6.49%-7.28%
Form 8-K Tvardi Therapeutics, For: Jul 07SEC filing · Form 8-K-0.86%+42.86%
Form 8-K Tvardi Therapeutics, For: Jun 09SEC filing · Form 8-K+0.00%-2.94%
Form EFFECT Tvardi Therapeutics,SEC filing · Form EFFECT+2.05%+1.28%
Form EFFECT Tvardi Therapeutics,SEC filing · Form EFFECT+0.00%+0.00%
Form 10-Q Tvardi Therapeutics, For: Mar 31SEC filing · Form 10-Q-3.06%-1.65%
Form 8-K Tvardi Therapeutics, For: May 08SEC filing · Form 8-K-3.06%-1.65%
Form POS AM Tvardi Therapeutics,SEC filing · Form POS+3.54%+0.25%
Form S-3 Tvardi Therapeutics,SEC filing · Form S-3+0.00%+13.46%
Form ARS Tvardi Therapeutics, For: Dec 31SEC filing · Form ARS+1.32%+2.31%
Form DEF 14A Tvardi Therapeutics, For: Jun 09SEC filing · Form DEF+1.32%+2.31%
Form DEFA14A Tvardi Therapeutics,SEC filing · Form DEFA14A+1.32%+2.31%
Form POS EX Tvardi Therapeutics,SEC filing · Form POS-3.45%-4.15%
Form S-8 Tvardi Therapeutics,SEC filing · Form S-8-3.45%-4.15%
Form 10-K Tvardi Therapeutics, For: Dec 31SEC filing · Form 10-K-3.45%-4.15%
Form 8-K Tvardi Therapeutics, For: Mar 31SEC filing · Form 8-K-3.45%-4.15%
Form 8-K Tvardi Therapeutics, For: Mar 06SEC filing · Form 8-K+0.00%+2.05%
Form 8-K Tvardi Therapeutics, For: Jan 16SEC filing · Form 8-K+0.00%+1.33%
Form 8-K Tvardi Therapeutics, For: Dec 16SEC filing · Form 8-K+0.00%+1.53%
Form 8-K Tvardi Therapeutics, For: Nov 19SEC filing · Form 8-K-0.25%-2.96%
Form S-1/A Tvardi Therapeutics,SEC filing · Form S-1-0.49%-6.24%
Form S-8 Tvardi Therapeutics,SEC filing · Form S-8-0.49%-6.24%
Form 8-K Tvardi Therapeutics, For: Oct 13SEC filing · Form 8-K-2.26%+5.26%
Form S-1/A Tvardi Therapeutics,SEC filing · Form S-1+0.00%-0.84%
Form 10-Q Tvardi Therapeutics, For: Jun 30SEC filing · Form 10-Q+0.00%-2.40%
Form 8-K Tvardi Therapeutics, For: Aug 14SEC filing · Form 8-K+0.00%-2.40%
Form 8-K Tvardi Therapeutics, For: Jul 08SEC filing · Form 8-K+0.00%-12.97%
Form 8-K Tvardi Therapeutics, For: Jun 06SEC filing · Form 8-K-3.67%-8.66%
Form S-1 Tvardi Therapeutics,SEC filing · Form S-1+3.35%-1.51%
Form 8-K Tvardi Therapeutics, For: May 27SEC filing · Form 8-K-1.09%+4.34%
Form SEC STAFF LETTER Cara Therapeutics, Inc.SEC filing · Form SEC+3.48%+3.10%
That’s how TVRD usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More TVRD: earnings → · analyst actions → · TVRD overview →